Bulgaria Pharmaceuticals and Healthcare Report - Q4 2014

Business Monitor International
September 10, 2014
103 Pages - SKU: BMI5325537
Countries covered: Bulgaria

Bulgaria Pharmaceuticals and Healthcare Report - Q4 2014

BMI View: The parlous situation of the NHIF and the inability of the Bulgarian parliament to agree on theinterim state budget present considerable risks to our 2014 and 2015 forecasts. Bulgaria's positiveeconomic outlook in 2014/15 will provide a safety buffer, but structural issues within the country'shealthcare system will require legislative reform from the Bulgarian parliament.

Headline Expenditure Projections

Pharmaceuticals: BGN2.32bn (USD1.58bn) in 2013 to BGN2.38bn (USD1.63bn) in 2014; +2.5% inlocal currency terms and 3.2% in US dollar terms. US dollar forecast revised upward due to expectationsof lev appreciation.



More Prescription Drugs reports by Business Monitor International

Venezuela Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Venezuela Pharmaceuticals and Healthcare Report Q4 2014BMI View: Venezuela's improving foreign currency supply, increasing pharmaceutical imports frompolitical allies and the potential expansion of free medicine ...
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014BMI View: The decline in NHS pharmaceutical expenditure in 2013, despite an increase in prescriptionnumbers, does not come ...
Switzerland Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Switzerland Pharmaceuticals and Healthcare Report Q4 2014BMI View: Most of Switzerland's demographic and economic indicators are favourable towards increasedpharmaceutical and healthcare spending. The proportion of ...
Qatar Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Qatar Pharmaceuticals and Healthcare Report Q4 2014BMI View: The reduction of a large number of medicine prices in Qatar is likely to be detrimental topharmaceutical ...
See all reports like this >>

More Bulgaria Prescription Drugs reports

Antibiotics Market in Bulgaria to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Bulgaria. The study provides essential market ...
The Pharmaceutical Market: Bulgaria (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!